信息搜索
信息关键字：药
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·药企医保双臂合力 老百姓的用药价格降了2023-1-18 19:51:08
·2023年创新药出海第一单：国产中枢神经系统新药出海“零”突破，打破国外技术垄断2023-1-18 19:17:53
·新华制药：取得加工阿兹夫定片所需的《药品生产许可证》C证2023-1-18 17:31:56
·新版国家医保药品目录公布新增111种药品2023-1-18 15:30:36
·2022年国家医保目录调整结果公布：新增111个药品，谈判药品降价60.1%2023-1-18 15:17:49
·实控人遭查、债务纠纷难题频现！阵痛中“东北参王”紫鑫药业怎解困？2023-1-18 13:58:21
·永顺生物获得新兽药注册证书2023-1-18 13:12:55
·1月18日午间公告：云南白药香藿喷雾剂获云南省医疗机构制剂注册批件2023-1-18 12:59:00
·富祥药业（300497）1月17日主力资金净卖出1578.25万元2023-1-18 12:21:55
·翰宇药业2022年预计亏损3.3亿-3.8亿同比由盈转亏研发费用上涨2023-1-18 11:44:56
·华海药业扣非涨超17倍汇兑收益提升联合辉瑞推药品本土化研发费率11.5%2023-1-18 11:44:17
·中国电建134亿定增落地为转型补充弹药新签合同金额增逾50%2023-1-18 10:36:33
·九典医疗净利润预计增长28.77%-33.66%新药上市将推动业绩继续增长2023-1-18 10:06:36
·紫鑫药业（002118）1月17日主力资金净买入124.56万元2023-1-18 9:39:58
·平安证券：春季躁动行情有望继续关注消费医药和新兴成长2023-1-18 0:01:07
·天意药业定向发行107.8万股股份募资总额646.8万2023-1-17 23:41:33
·1500元/瓶！又有新冠口服药挂网采购2023-1-17 22:24:07
·方盛制药2022年预计净利2.8亿-3.2亿同比增加300%-357%依折麦布片等产品销售收入增长2023-1-17 22:03:42
·奥翔药业2022年预计净利2.19亿-2.48亿同比增加50%-70%特色原料药业务增长2023-1-17 21:59:17
·药明生物大股东上演完美撤退上市五年半配售套现770亿港元2023-1-17 16:40:51

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]